Literature DB >> 14617701

Human cellular inflammation in the pathology of acute cerebral ischaemia.

C J S Price1, E A Warburton, D K Menon.   

Abstract

Leucocytes form important effector pathways for inflammation. This article reviews the clinical evidence for the presence of a cellular inflammatory response in cerebral ischaemia, and attempts to define its temporal profile and spatial distribution. The processes involved in recruitment and activation of leucocytes in this context are addressed, and the successes and failures of interventions aimed at these processes discussed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14617701      PMCID： PMC1738225          DOI： 10.1136/jnnp.74.11.1476

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  79 in total

Review 1.  Chemokines in the brain: neuroimmunology and beyond.

Authors:  Knut Biber; Mike W Zuurman; Inneke M Dijkstra; Hendrikus W G M Boddeke
Journal:  Curr Opin Pharmacol       Date:  2002-02       Impact factor: 5.547

Review 2.  Locking a leukocyte integrin with statins.

Authors:  P S Frenette
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 3.  Inflammation and infection in clinical stroke.

Authors:  Hedley C A Emsley; Pippa J Tyrrell
Journal:  J Cereb Blood Flow Metab       Date:  2002-12       Impact factor: 6.200

Review 4.  The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection.

Authors:  A L D'Ambrosio; D J Pinsky; E S Connolly
Journal:  Mol Med       Date:  2001-06       Impact factor: 6.354

5.  Cerebrospinal fluid cytology after stroke.

Authors:  R Sörnäs; H Ostlund; R Müller
Journal:  Arch Neurol       Date:  1972-06

6.  Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke.

Authors:  J Losy; J Zaremba
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

7.  Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial.

Authors: 
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

8.  Methylprednisolone acts on peripheral blood mononuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosis.

Authors:  Maurizio Gelati; Elena Corsini; Marco De Rossi; Laura Masini; Gaetano Bernardi; Giorgio Massa; Amerigo Boiardi; Andrea Salmaggi
Journal:  Arch Neurol       Date:  2002-05

Review 9.  Inflammatory cell adhesion molecules in ischemic cerebrovascular disease.

Authors:  C J M Frijns; L J Kappelle
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

10.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690
View more
  14 in total

Review 1.  Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage.

Authors:  Perttu Johannes Lindsberg; Daniel Strbian; Marja-Liisa Karjalainen-Lindsberg
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

2.  In vivo assessment of macrophage CNS infiltration during disruption of the blood-brain barrier with focused ultrasound: a magnetic resonance imaging study.

Authors:  Hao-Li Liu; Yau-Yau Wai; Po-Hong Hsu; Lee-Ang Lyu; Jia-Shin Wu; Chia-Rui Shen; Jin-Chung Chen; Tzu-Chen Yen; Jiun-Jie Wang
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-02       Impact factor: 6.200

Review 3.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

4.  A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.

Authors:  In-Young Choi; Jae-Chul Lee; Chung Ju; Sunyoung Hwang; Geum-Sil Cho; Hyuk Woo Lee; Won Jun Choi; Lak Shin Jeong; Won-Ki Kim
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

Review 5.  Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications.

Authors:  J Marc Simard; Thomas A Kent; Mingkui Chen; Kirill V Tarasov; Volodymyr Gerzanich
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

6.  Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection.

Authors:  A D Greenhalgh; J Galea; A Dénes; P J Tyrrell; Nancy J Rothwell
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

Review 7.  Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery.

Authors:  R R Moustafa; J-C Baron
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 8.  Epigenetic mechanisms in cerebral ischemia.

Authors:  Sophie Schweizer; Andreas Meisel; Stefanie Märschenz
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-12       Impact factor: 6.200

9.  Concussions: What a neurosurgeon should know about current scientific evidence and management strategies.

Authors:  Matthew T Neal; Jonathan L Wilson; Wesley Hsu; Alexander K Powers
Journal:  Surg Neurol Int       Date:  2012-02-15

10.  A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients.

Authors:  H C A Emsley; C J Smith; R F Georgiou; A Vail; S J Hopkins; N J Rothwell; P J Tyrrell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.